EcoR1 Capital Fund Qualified, L.P.'s Net Worth
$87.6 Million
Who is EcoR1 Capital Fund Qualified, L.P.?
EcoR1 Capital Fund Qualified, L.P. has an estimated net worth of $87.6 Million. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Kura Oncology, Inc., Panacea Acquisition Corp. II, ASSEMBLY BIOSCIENCES, INC., aTYR PHARMA INC, and GENVEC INC.
SEC CIK
EcoR1 Capital Fund Qualified, L.P.'s CIK is 0001598292
Past Insider Trading and Trends
2021 was EcoR1 Capital Fund Qualified, L.P.'s most active year for acquiring shares with 23 total transactions. EcoR1 Capital Fund Qualified, L.P.'s most active month to acquire stocks was the month of January. 2017 was EcoR1 Capital Fund Qualified, L.P.'s most active year for disposing of shares, totalling 4 transactions. EcoR1 Capital Fund Qualified, L.P.'s most active month to dispose stocks was the month of October. 2021 saw EcoR1 Capital Fund Qualified, L.P. paying a total of $40,122,961.55 for 15,374,562 shares, this is the most they've acquired in one year. In 2018 EcoR1 Capital Fund Qualified, L.P. cashed out on 3,235,836 shares for a total of $3,349,119.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvation Bio Inc. (NUVB) Snapshot price: $1.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +72.17% | 5.31M |
$1.26 | $6,692,265.10 | 12.67M |
Sep 19 - Sep 21
| |||
Form 4
| +72.17% | 5.31M |
$1.26 | $6,692,265.10 | 12.67M |
Feb 19 - Feb 21
| |||
Form 4
| +3.07% | 488.11K |
$8.89 | $4,589,360.93 | 16.41M |
Mar 31 - Nov 24
| |||
Form 4
| +5.89% | 464.5K |
$9.89 | $4,594,593.90 | 8.35M |
Apr 9 - Apr 13
| |||
Form 4
| +162.95% | 12.86M |
$10.00 | $25,000,000.00 | 20.75M |
Feb 10
| |||
Form 4
|
∞
| 390K |
$10.00 | $3,900,000.00 | 390K |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kura Oncology, Inc. (KURA) Snapshot price: $20.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.44% | 187.37K |
$13.39 | $2,551,769.34 | 4.41M |
Dec 17 - Dec 21
| |||
Form 4
| +0.97% | 40.54K |
$13.90 | $563,362.39 | 4.22M |
Dec 11 - Dec 13
| |||
Form 4
| +1.46% | 119.91K |
$13.50 | $1,618,254.85 | 8.34M |
Dec 3 - Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Panacea Acquisition Corp. II No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -545.00K |
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
∞
| 545K |
$10.00 | $5,450,000.00 | 545K |
Apr 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ASSEMBLY BIOSCIENCES, INC. (ASMB) Snapshot price: $0.9802
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
aTYR PHARMA INC (LIFE) Snapshot price: $1.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.21M |
$0.93 | -$2,999,055.65 |
0
|
May 14 - May 16
| |||
Form 4
| +0.49% | 15.78K |
$4.46 | $86,858.63 | 3.21M |
Oct 1 - Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||